Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 71
Appendix D
Workshop Speakers
Biographical Sketches
Charles M. Anderson, M. D., Ph.D., is the chief consultant for diagnostic
services in the Veterans Health Administration. He prepares policy and
coordinates national diagnostic initiatives. Dr. Anderson received a Ph.D. in
molecular biophysics and biochemistry from Yale University, an M.D. from
Stanford University, and residency training in diagnostic radiology from
University of California, San Francisco (UCSF). Dr. Anderson was a clinical
professor of radiology at UCSF until 2008. He is a practicing radiologist at
Durham North Carolina VA Medical Center.
David J. Brenner, Ph.D., is the director of the Center for Radiological
Research at Columbia University, as well as the director of the Radiologi-
cal Research Accelerator Facility and principal investigator of the Center
for High-Throughput Minimally-lnvasive Radiation Biodosimetry, which
focuses on developing mechanistic models for the effects of ionizing radia-
tion on living systems, both at the chromosomal and animal levels. He
divides his research time between the effects of high doses of ionizing radia-
tion (relating to radiation therapy) and the effects of low doses of radiation
(relating to medical, environmental, and occupational exposures).
James A. Brink, M.D., is professor and chair of the Department of Diag-
nostic Radiology at Yale University School of Medicine. He earned a B.S.
degree in electrical engineering at Purdue University and an M.D. at Indi-
ana University before completing his residency and fellowship at Mas-
sachusetts General Hospital. While he has broad experience in medical
71
OCR for page 72
72 APPENDIX D
imaging, including utilization and management of imaging resources, he
has particular interest and expertise in issues related to the monitoring and
control of medical radiation exposure, which can be compounded if testing
is superfluous, unnecessary, or redundant.
Mythreyi Bhargavan Chatfield, Ph.D., is the director of data registries at
the American College of Radiology (ACR) in Reston, Virginia. In this posi-
tion, she manages national registries focused on improving practice quality
in radiology. Dr. Chatfield’s current areas of focus include practice quality
in radiology, performance metrics, and radiation doses from medical pro-
cedures. She is a council member of the National Council on Radiation
Protection and Measurements (NCRP), an organization chartered by the
U.S. Congress to develop expert consensus on issues related to radiation
protection using independent scientific analysis. She has a Ph.D. in econom-
ics from Rutgers University.
Gwen Darien is a cancer survivor who brings a wealth of personal and
professional experiences to her position as executive director of the Samuel
Waxman Cancer Research Foundation. She was the founding director of the
American Association for Cancer Research’s (AACR) department of Survi-
vor and Patient Advocacy. Ms. Darien was editor-in-chief of CR magazine
and director of the American Association for Cancer Research Survivor
and Patient Advocacy Program. She was previously the editor-in-chief of
MAMM. Ms. Darien is chair of the National Cancer Institute (NCI) Direc-
tor’s Consumer Liaison Group and is a member of the Board of Directors
of Education Network to Advance Cancer Clinical Trials. She has served
as member of the Secretary’s Advisory Committee on Health, Genetics
and Society and the faculties of the AACR/American Society of Clinical
Oncology Methods in Clinical Cancer Research Workshop, Accelerating
Anti-Cancer Agent Development and on the advisory board of the Health
Advocacy Program at Sarah Lawrence College.
Kenneth Denison, Ph.D., is responsible for leading all dose-related activities
for General Electric (GE) Healthcare’s CT business including lower-dose
technologies, dose monitoring and tracking systems, new services and solu-
tions, education and training, and coordination of industry, public, and
government relations activities relative to the dose issue. His focus is on
helping GE Healthcare customers worldwide lower the radiation doses used
in their practices. He holds seven patents, all in the design of MRI systems.
He received both his B.S. and Ph.D. degrees in chemical engineering from
the University of Kentucky in Lexington.
OCR for page 73
73
APPENDIX D
Donald P. Frush, M.D., F.A.C.R., F.A.A.P., is professor of radiology and
pediatrics, chief of pediatric radiology and vice-chair for safety and quality,
Department of Radiology, Duke Medical Center. He is also a councilor for
NCRP, and he is on the boards of both the ACR and American Board of
Radiology (ABR). He is a fellow in the Society of Computed Tomography
and Magnetic Resonances, a steering committee member of the Alliance for
Radiation Safety in Pediatric Imaging (Image Gently Campaign), and works
with the International Atomic Energy Agency (IAEA) Smartcard Radiation
Tracking Project. Research includes CT image quality, dose assessment, and
dose reduction in children.
Katharine Grant, Ph.D., is currently a CT staff scientist for Siemens Medi-
cal Solutions USA and serves as a collaboration manager/scientific liaison
between luminary customers and Siemens’ physicists. Dr. Grant joined
Siemens in 2009 after being awarded a post-doctoral fellowship from the
Director of Central/National Intelligence and working as a research associ-
ate within the Special Purpose Processor Development Group (SPPDG) at
the Mayo Clinic. She received her B.S. in physics from Miami University in
2000 and her Ph.D. in biomedical engineering from the Mayo Clinic Col-
lege of Medicine in 2005. Dr. Grant is also an adjunct assistant professor
of radiology and physiology at the Mayo Clinic.
Michael S. Lauer, M.D., has served as director of the Division of Cardio-
vascular Sciences at the National Heart, Lung, and Blood Institute. Dr.
Lauer is a cardiologist and clinical epidemiologist noted for his work on
diagnostic testing, clinical manifestations of autonomic nervous system
dysfunction, and clinical comparative effectiveness. Dr. Lauer received a
B.S. in biology from the Rensselaer Polytechnic Institute and an M.D. from
Albany Medical College; he also participated in the Program in Clinical
Effectiveness at the Harvard School of Public. He received post-graduate
training at Massachusetts General Hospital, Boston’s Beth Israel Hospital,
and the Framingham Heart Study. Prior to joining the National Institute of
Health (NIH), Dr. Lauer was a professor of medicine, epidemiology, and
biostatistics at the Cleveland Clinic Lerner College of Medicine of Case
Western Reserve University.
Kiyohiko Mabuchi, M.D., M.P.H., deputy chief, Radiation Epidemiology
Branch, head of the Chernobyl Research Unit, and senior scientist, in the
Division of Cancer Epidemiology and Genetics at the NCI, currently directs
epidemiological studies of thyroid disease and leukemia risks following
the Chernobyl nuclear reactor accident and also is engaged in continu-
ing follow-up studies of cancer in the Japanese atomic-bombing survi-
OCR for page 74
74 APPENDIX D
vors, collaborating with the Radiation Effects Research Foundation. He
received an M.D. from Osaka University Medical School and an M.P.H./
Dr.P.H. from the John Hopkins University School of Hygiene and Public
Health. He has been a member of several international radiation commit-
tees, including the International Commission of Radiological Protection
(ICRP), the United Nations Scientific Committee on the Effects of Atomic
Radiation (UNSCEAR), and the UK National Radiological Protection
Board’s Advisory.
Richard Mather, Ph.D., has worked in medical imaging for more than 17
years including formal training at University of California, Los Angeles, in
the biomedical physics graduate program. He received his Ph.D. in 1997. At
Toshiba, Dr. Mather has been integrally involved in research projects that
validate Toshiba’s CT products in the medical community.
Michael McNitt-Gray, Ph.D., is professor of radiological sciences in the
David Geffen School of Medicine at UCLA. He is also the director of
the biomedical physics graduate program there. He received his Ph.D. in
biomedical physics from UCLA in 1993; his MSEE from Carnegie Mellon
University in 1980, and his BSEE from Washington University in St. Louis
in 1979. He currently serves on the International Commission on Radiation
Units (ICRU) Committee on Image Quality and Patient Dose in Computed
Tomography, and he chairs both the ACR CT Accreditation Program Phys-
ics subcommittee and the American Association of Physicists in Medicine
CT Subcommittee. His current research interests include investigations into
x-ray computed tomography with specific research into the physics of CT
image acquisition including estimating radiation dose and assessing image
quality.
Charles W. Miller, Ph.D., joined the Centers for Disease Control and Pre-
vention in January 1992. He is currently chief of the Radiation Studies
Branch, Division of Environmental Hazards and Health Effects, National
Center for Environmental Health. In this position, he develops goals and
objectives that integrate organization and environmental public health pro-
grams on the potential effects of exposure to radiation and radiation-related
health research, including providing leadership for the agency’s radiological
emergency response and consequence management efforts. Dr. Miller is a
member of the NCRP, and he is a fellow of the Health Physics Society. Dr.
Miller holds a B.S. in physics/math from Ball State University, a M.S. in
meteorology from the University of Michigan, and a Ph.D. in bionucleonics
(health physics) from Purdue University.
OCR for page 75
75
APPENDIX D
Donald L. Miller, M.D., is acting chief, Diagnostic Devices Branch, Divi-
sion of Mammography Quality and Radiation Programs in the Center for
Devices and Radiological Health of the FDA. He received a B.A. in molecu-
lar biophysics and biochemistry from Yale University in 1972 and an M.D.
from the New York University School of Medicine in 1976. He is a fellow
of the Society of Interventional Radiology and the ACR, a consultant to
the IAEA, a member of Council of the NCRP, and a member of Committee
3 of the ICRP.
Gail Prochaska has been with IMV since 1987 during which time she has
worked with vendors and professional societies to develop and use market
data and census databases to capture procedures, consumables, and equip-
ment for multiple diagnostic imaging modalities and radiation therapy.
Prior to IMV, Ms. Prochaska held marketing, sales, and management posi-
tions at Amersham (now GE). She has a B.S. in biology from the University
of Illinois at Champaign-Urbana.
Madan M. Rehani, Ph.D., has been working at IAEA, Vienna, Austria for
the past 10 years and manages radiation protection of patients projects
in more than 60 countries. He is responsible for initiating and directing
patient radiation exposure tracking project at IAEA. Prior to joining IAEA
he was professor and head at the Medical Physics Unit at the All India
Institute of Medical Sciences, New Delhi. He has chaired three task groups
of the ICRP, which led to Annals of ICRP.
Ashok Shah, M.B.A., is the general manager of IMV Ltd. and has more
than 30 years’ experience in the health care and scientific products markets.
Prior to IMV, Mr. Shah held positions with IMS Health, Fisher Scientific,
and Becton Dickinson & Co. He has an M.B.A. from McGill University,
Montreal, and a B.S. in microbiology.
Dominic Siewko is the radiation safety officer for Philips Healthcare and
has been in this role for two years. He previously worked for GE Healthcare
for the past 10 years in a health physicist position supporting radiopharma-
ceutical manufacturing. He currently manages the radiation/product safety
and radiation regulatory program for all nuclear and x-ray imaging modali-
ties globally for Philips and is based out of Andover, Massachusetts. He is
active in the Medical Imaging and Technology Alliance, Society of Nuclear
Medicine, and Health Physics Society, and is certified by the American
Board of Health Physics.
OCR for page 76
76 APPENDIX D
Aaron Sodickson, M.D., is the section head of emergency radiology at
Brigham and Women’s Hospital, medical director of CT for the Brigham
Radiology Network, and assistant professor of radiology at Harvard Medi-
cal School. His primary research focus is on informatics methods to auto-
matically extract radiation exposure data on a large scale from existing
sources in the electronic medical record, and use of the resultant data-
bases for quality control and patient safety applications. Related research
and clinical quality improvement efforts involve CT technology assessment
and imaging optimization to achieve high-quality imaging at low radiation
dose.
David C. Spelic, Ph.D., is a physicist with the FDA’s Center for Devices and
Radiological Health. He joined the agency in 1994, and he is involved in
public health activities regarding medical x-ray based imaging. He also has
primary responsibility for the Nationwide Evaluation of X-ray Trends sur-
vey program, a cooperative effort with the Conference of Radiation Control
Program Directors and state-level radiation control offices to character-
ize patient radiation doses from selected medical x-ray examinations per-
formed in the United States.
Raymond H. Thornton, M.D., trained as a concert pianist at the Juilliard
School before attending medical school at the University of Pittsburgh.
He completed residency in diagnostic radiology and fellowship training
in vascular interventional radiology at the University of California at San
Francisco. At Memorial Sloan-Kettering Cancer Center, he serves as vice-
chair of Radiology for Quality, Safety and Performance Improvement and
Training Program Director for the Interventional Radiology fellowship, in
addition to maintaining a busy clinical practice in interventional radiology.
